Top Stock Losers
Explore the biggest stock losers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock losers and decliners every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Innovative Industrial Properties Stock Plunged Today
Jeremy Bowman
|
Dec 20, 2024
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up
Rich Smith
|
Dec 20, 2024
Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.
Is Novo Nordisk Stock a Buy?
Alex Carchidi
|
Nov 29, 2024
Is Novo Nordisk Stock a Buy Right Now?
Adam Spatacco
|
Nov 20, 2024
Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.
Why Innovative Industrial Properties Stock Crumbled Today
Eric Volkman
|
Nov 7, 2024
Cannabis assets are out of favor just now, and the company's latest news didn't improve the situation.
Innovative Industrial Properties (IIPR) Q3 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Nov 7, 2024
IIPR earnings call for the period ending September 30, 2024.
Novo Nordisk (NVO) Q3 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Nov 6, 2024
NVO earnings call for the period ending September 30, 2024.
This Is Huge News for Novo Nordisk (Hint: It Doesn't Involve Ozempic)
Adam Spatacco
|
Oct 26, 2024
Novo Nordisk just released data from a clinical trial featuring its oral semaglutide treatment, Rybelsus.
2 No-Brainer Dividend Growth Stocks to Buy Right Now
George Budwell
|
Oct 10, 2024
These two pharmaceutical giants are positioned for growth with their innovative diabetes and obesity treatments.
Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
Alex Carchidi
|
Sep 27, 2024
The thrust of the company's long-term strategy is becoming clearer.
View More Articles